Prosecution Insights
Last updated: August 18, 2026

Examiner: BOUCHELLE, LAURA A

Tech Center 3700 • Art Units: 3763 3771 3783 3791

This examiner grants 80% of resolved cases

Performance Statistics

80.3%
Allow Rate
+10.3% vs TC avg
1,247
Total Applications
+10.4%
Interview Lift
1175
Avg Prosecution Days
Based on 1213 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
25.5%
§102 Novelty
47.3%
§103 Obviousness
15.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18300966 VARIABLE STIFFNESS MULTI-LUMEN TUBE Final Rejection Boston Scientific Scimed, Inc.
18743859 METHOD AND APPARATUS FOR USING OMALIZUMAB Final Rejection Genentech, Inc.
18078705 INTRAVENOUS PRESSURE ASSEMBLY Final Rejection CareFusion 303, Inc.
18072183 INTRAVENOUS SET HAND PUMP Final Rejection CareFusion 303, Inc.
17798754 ALTERNATIVE CANNULA CONFIGURATIONS TO CONTROL FLUID DISTRIBUTION IN TISSUE Non-Final OA Merck Sharp & Dohme LLC
18716612 Stopper for a Syringe Having Anti-Sticking Features Non-Final OA Becton, Dickinson and Company
18709333 Catheter Securement Device Non-Final OA Becton, Dickinson and Company
17710015 Instrument Advancement Device Having an Indicator Marking Non-Final OA Becton, Dickinson and Company
18694113 Electronic system, user interface member, drug delivery device and method for detecting whether a drug delivery device is, or was, exposed to fluid Non-Final OA Sanofi
18289267 CODED HOUSING COMPONENTS FOR AN INJECTION DEVICE Final Rejection Sanofi
18710712 PERITONEAL DIALYSIS SYSTEM HAVING A PATIENT LINE FILTER Non-Final OA BAXTER HEALTHCARE SA
18730587 Port Identification Insert and Assembly Alignment Feature Non-Final OA Bard Peripheral Vascular, Inc.
17425068 GUIDE EXTENSION CATHETER Final Rejection Teleflex Life Sciences LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month